Vasoactive Agent Use in Septic Shock: Beyond First-Line Recommendations.
Gretchen L SachaSeth R BauerIshaq LatPublished in: Pharmacotherapy (2019)
Septic shock is a life-threatening disorder associated with high mortality rates requiring rapid identification and intervention. Vasoactive agents are often required to maintain goal hemodynamics and preserve tissue perfusion. However, guidance regarding the proper administration of adjunct agents for the management of septic shock is limited in patients who are refractory to norepinephrine. This review summarizes vasopressor agents and describes the nuanced application of these agents in patients with septic shock, specifically focusing on clinical scenarios with limited guidance including patients who are nonresponsive to first-line agents and individuals with mixed shock states, tachyarrhythmias, obesity, valvular abnormalities, or other comorbid conditions.
Keyphrases
- septic shock
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- type diabetes
- randomized controlled trial
- prognostic factors
- metabolic syndrome
- peritoneal dialysis
- insulin resistance
- magnetic resonance
- adipose tissue
- body mass index
- computed tomography
- skeletal muscle
- aortic valve
- weight gain
- cardiovascular events
- clinical practice
- physical activity